Pay in 4 interest-free payments of $5.60 Learn more
Ships within 48 hours · Estimated delivery Sep 1 - Sep 6
AOD-9604 is not FDA-approved or TGA-approved for any indication
Effective for persistent injuries unresponsive to standard treatments, providing the therapeutic intensity needed for stubborn healing challenges
In a 56-day phase-2 trial, 9 participants with severe dry eye syndrome were treated with synthetic TB4 eye drops or placebo for 28 days, followed by a 28-day observational period
Why Quality Matters from the Start All the proper storage techniques in the world can't fix a product that was low-quality to begin with
According to a 2021 study published in Frontiers in Pharmacology, BPC-157 peptides may help wound healing ( 4 )
In wissenschaftlichen Studien wurde BPC-157 hauptschlich im Kontext von Gewebeuntersttzung untersucht
